RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 1 filers reported holding RAPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,686,133 | -0.4% | 221,789 | +12.1% | 0.00% | 0.0% |
Q2 2023 | $3,699,702 | +3.4% | 197,845 | +1.5% | 0.00% | 0.0% |
Q1 2023 | $3,577,626 | +5.6% | 194,966 | +13.9% | 0.00% | 0.0% |
Q4 2022 | $3,389,503 | -15.4% | 171,187 | +2.8% | 0.00% | 0.0% |
Q3 2022 | $4,006,000 | +44.0% | 166,487 | +9.2% | 0.00% | 0.0% |
Q2 2022 | $2,782,000 | -13.3% | 152,418 | +4.5% | 0.00% | 0.0% |
Q1 2022 | $3,207,000 | -38.6% | 145,818 | +2.6% | 0.00% | -50.0% |
Q4 2021 | $5,219,000 | +19.9% | 142,073 | +1.4% | 0.00% | +100.0% |
Q3 2021 | $4,352,000 | +69.5% | 140,134 | +73.5% | 0.00% | 0.0% |
Q2 2021 | $2,568,000 | +75.2% | 80,760 | +22.4% | 0.00% | 0.0% |
Q1 2021 | $1,466,000 | +11.8% | 66,003 | -0.5% | 0.00% | 0.0% |
Q4 2020 | $1,311,000 | -37.7% | 66,345 | +1.4% | 0.00% | 0.0% |
Q3 2020 | $2,106,000 | +40.2% | 65,397 | +26.4% | 0.00% | 0.0% |
Q2 2020 | $1,502,000 | +138.0% | 51,756 | +74.7% | 0.00% | – |
Q1 2020 | $631,000 | +40.8% | 29,632 | +82.9% | 0.00% | – |
Q4 2019 | $448,000 | – | 16,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |